Your browser doesn't support javascript.
loading
18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.
Valkema, Maria J; de Lussanet de la Sablonière, Quido G; Valkema, Roelf; Thomeer, Maarten G J; Dwarkasing, Roy S; Harteveld, Anita A; Doukas, Michail; Mostert, Bianca; van der Zijden, Charlène J; van der Sluis, Pieter C; Lagarde, Sjoerd M; Wijnhoven, Bas P L; Verburg, Frederik A; van Lanschot, J Jan B.
Affiliation
  • Valkema MJ; Departments of Surgery.
  • de Lussanet de la Sablonière QG; Radiology and Nuclear Medicine.
  • Valkema R; Radiology and Nuclear Medicine.
  • Thomeer MGJ; Radiology and Nuclear Medicine.
  • Dwarkasing RS; Radiology and Nuclear Medicine.
  • Harteveld AA; Radiology and Nuclear Medicine.
  • Doukas M; Pathology.
  • Mostert B; Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van der Zijden CJ; Departments of Surgery.
  • van der Sluis PC; Departments of Surgery.
  • Lagarde SM; Departments of Surgery.
  • Wijnhoven BPL; Departments of Surgery.
  • Verburg FA; Radiology and Nuclear Medicine.
  • van Lanschot JJB; Departments of Surgery.
Nucl Med Commun ; 45(2): 128-138, 2024 Feb 01.
Article in En | MEDLINE | ID: mdl-37982560

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Fluorodeoxyglucose F18 Limits: Aged / Humans / Male Language: En Journal: Nucl Med Commun Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Fluorodeoxyglucose F18 Limits: Aged / Humans / Male Language: En Journal: Nucl Med Commun Year: 2024 Type: Article